245 related articles for article (PubMed ID: 27631090)
1. Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.
Christensen SM; Dillon LA; Carvalho LP; Passos S; Novais FO; Hughitt VK; Beiting DP; Carvalho EM; Scott P; El-Sayed NM; Mosser DM
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004992. PubMed ID: 27631090
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
[TBL] [Abstract][Full Text] [Related]
3. Molecular variants of Leishmania (Viannia) braziliensis trigger distinct patterns of cytokines and chemokines expression in golden hamster.
Rêgo FD; Fradico JRB; Teixeira-Carvalho A; Gontijo CMF
Mol Immunol; 2019 Feb; 106():36-45. PubMed ID: 30576950
[TBL] [Abstract][Full Text] [Related]
4. Amastin Knockdown in Leishmania braziliensis Affects Parasite-Macrophage Interaction and Results in Impaired Viability of Intracellular Amastigotes.
de Paiva RM; Grazielle-Silva V; Cardoso MS; Nakagaki BN; Mendonça-Neto RP; Canavaci AM; Souza Melo N; Martinelli PM; Fernandes AP; daRocha WD; Teixeira SM
PLoS Pathog; 2015 Dec; 11(12):e1005296. PubMed ID: 26641088
[TBL] [Abstract][Full Text] [Related]
5. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Analysis of Human Skin Lesions Identifies Tryptophan-2,3-Deoxygenase as a Restriction Factor for Cutaneous
Rodrigues V; André S; Maksouri H; Mouttaki T; Chiheb S; Riyad M; Akarid K; Estaquier J
Front Cell Infect Microbiol; 2019; 9():338. PubMed ID: 31637219
[TBL] [Abstract][Full Text] [Related]
7. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
8. A Cytokine Network Balance Influences the Fate of
Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
Front Immunol; 2021; 12():656919. PubMed ID: 34276650
[TBL] [Abstract][Full Text] [Related]
9. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
10. Leishmania amazonensis downregulates macrophage iNOS expression via Histone Deacetylase 1 (HDAC1): a novel parasite evasion mechanism.
Calegari-Silva TC; Vivarini ÁC; Pereira RMS; Dias-Teixeira KL; Rath CT; Pacheco ASS; Silva GBL; Pinto CAS; Dos Santos JV; Saliba AM; Corbett CEP; de Castro Gomes CM; Fasel N; Lopes UG
Eur J Immunol; 2018 Jul; 48(7):1188-1198. PubMed ID: 29645094
[TBL] [Abstract][Full Text] [Related]
11. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology.
Novais FO; Carvalho LP; Passos S; Roos DS; Carvalho EM; Scott P; Beiting DP
J Invest Dermatol; 2015 Jan; 135(1):94-101. PubMed ID: 25036052
[TBL] [Abstract][Full Text] [Related]
13. Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
Almeida L; Silva JA; Andrade VM; Machado P; Jamieson SE; Carvalho EM; Blackwell JM; Castellucci LC
Infect Genet Evol; 2017 Apr; 49():212-220. PubMed ID: 28119029
[TBL] [Abstract][Full Text] [Related]
14. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of
Sandoval Pacheco CM; Araujo Flores GV; Gonzalez K; de Castro Gomes CM; Passero LFD; Tomokane TY; Sosa-Ochoa W; Zúniga C; Calzada J; Saldaña A; Corbett CEP; Silveira FT; Laurenti MD
J Immunol Res; 2021; 2021():5596876. PubMed ID: 33937417
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin in the host response to Leishmania amazonensis.
Giraud E; Rouault E; Fiette L; Colle JH; Smirlis D; Melanitou E
BMC Microbiol; 2019 Feb; 19(1):32. PubMed ID: 30736736
[TBL] [Abstract][Full Text] [Related]
17. Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis.
de O Mendes-Aguiar C; Lopes-Siqueira C; Pettito-Assis F; Pereira-Oliveira M; de Oliveira-Neto MP; Pirmez C; Da-Cruz AM; Goto H
J Immunol Res; 2021; 2021():6657785. PubMed ID: 33860062
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.
Lago J; Silva JA; Borja L; Fraga DBM; Schriefer A; Arruda S; Lago E; Carvalho EM; Bacellar O
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007532. PubMed ID: 31310601
[TBL] [Abstract][Full Text] [Related]
19. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans.
Maretti-Mira AC; Bittner J; Oliveira-Neto MP; Liu M; Kang D; Li H; Pirmez C; Craft N
PLoS Negl Trop Dis; 2012; 6(9):e1816. PubMed ID: 23029578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
